BOYNTON BEACH, Fla. and NASSAU, Bahamas, May 12, 2004 (PRIMEZONE) -- Harvey Grossman, President, Chief Operating Officer and Chief Knowledge Officer of Jacobson Resonance Enterprises, Inc., (OTCBB:JRSE) announced today that our joint venture partner in Nassau, Bahamas, Magnetic Resonance Therapy Bahamas Limited, has evolved into a center specializing in restoring quality of life to our clients and patients. This transformation has taken place in light of the profound healing that long-suffering patients are achieving. This development has short and long-term positive implications for the emerging business model of treatment centers outside the USA.
Examples of clients and patients now enjoying much improved quality of life:
Eleven-year Parkinson sufferer; two individuals with diabetic neuropathy; world-class pianist with crippling arthritis of the hands; male with congenital malformed hip and osteo-arthritis in both hips; female with fibromyalgia, Chronic Fatigue Syndrome and a history of Dengue Fever; female with Hypothyroidism, Chronic Fatigue Syndrome (Epstein Barr) and multiple Ciguatera Fish Poisoning; female suffering from life-long tension and migraine headaches; female with advanced osteo-arthritis of the neck including complexes of bone spurs; male with long-lived back, leg and ankle injuries; forty year-old male Bahamian National Soccer Team Goalie with chronic knee injury and hamstring pull healed in four days; thirty-three year old male Bahamian National Soccer Team star with five-year old major surgically repaired knee played without a brace for the first time since the surgery.
These results were achieved by focusing on quality care, extended treatment sessions, individual attention, and a mutual commitment from patient and therapist alike to see through the course of treatments. Quoting Mr. Grossman: "We now have a viable fee based business model that utilizes Magnetic Resonance Therapy (MRT) with Jacobson Resonators in a clinical setting. With quality care and sufficient exposure time in MRT there is a very high probability that a client will achieve profound relief and have quality of life restored. Through proper training and education we foresee that this model can be duplicated in the Caribbean Basin and indeed world-wide outside the United States."
Dr. Jerry I. Jacobson, JRSE Chairman, Chief Executive Officer and Chief Science & Technology Officer: "The most important aspect of our Bahamian operation is an opportunity that allows us to explore new territory in the Science of Bioelectromagnetics. Never before has there been a modality to utilize naturally occurring physical properties of biological systems to heal a wide diversity of disorders consistently and with an empirical, rigorous basis in mathematics. The discreet resonances that have been demonstrated in a clinical setting are truly profound and speak to a potential uplifting in spirit. The discovery made here in the Bahamas will certainly serve the world-wide commercialization effort of JRSE in the most beneficial way as we pursue various applications of what is clearly a fundamental truth in biology and the physical sciences."
Dr. Conville Brown, Chief Executive Officer of the Centreville Medical Pavilion in Nassau comments: "We at The Centreville Medical Pavilion are pleased to be an integral part of this venture with JRSE in what may well be medical history in the making as we endeavor to help out patients through the implementation of innovative techniques and technology. I personally look forward to potential uses of Magnetic Resonance Therapy in the management of cardiac and cancer patients."
JRSE is an emerging worldwide leader in magnetic resonance technology, whose main focus is the eradication of human suffering. The Company's technology base has the potential for multiple industry applications including the fields of healthcare, veterinary medicine, the leisure, spa, beauty and sports arenas, food and beverage, pharmaceuticals, energy and the environment.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The matters covered by such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements of the Company to differ materially from those contemplated or implied by such forward-looking statements. Included in these risks and other factors are funding availability, competition from better-financed companies and required regulatory clearances.